Events
  • 11
    2022-04

    KBI’s Research Service Capacity Boosted to a New High

    KBIisveryproudtoannounceahugeboosttoitsresearchservicecapacitytoanewhighin2022.Thenewly-boostedcapacityincludesahugeexpansionofKBI’slaboratoryspaceandacquisitionofthestate-of-the-artimagingfacilities.ByMarch2022,KBIhas

  • 07
    2022-04

    Annual Training of Laboratory Animal Use and Management

    KBIconductedanannualtrainingofanimaloperationskillsonApril6,2022.ExpertsfromYunnanUniversityandKunmingMedicalUniversitywereinvitedtosharetheirexperience.Approximately100KBIstaffmembersattendedthistrainingandrefreshedthe

  • 15
    2022-02

    FDA’s Approval of the Clinical Trial on B1344 for the treatment of NASH

    TheFDA(USA)hasrecentlyapprovedoftheclinicaltrialontheinvestigationalnewdrugB1344forthetreatmentofnonalcoholicsteatohepatitis(NASH).https://med.sina.com/article_detail_100_2_111927.htmlKBI,ShanghaiInstituteofNutritionand

  • 30
    2022-01

    Latest Research Paper in Cell Metabolism Describes the Study Performed at KBI

    ThelatestissueofCellMetabolismhaspublishedthefollowingresearchpaperwhichrevealanewtriagonisttargetingatGLP-1/GIP/GCGreceptorsfortheeffectivecontrolofbodyweightandbloodglucose(Openaccess:https://doi.org/10.1016/j.cmet.20

  • 17
    2021-08

    “Fresh Blood” for KBI ——2021 Welcome New Staff to KBI

    2021isaveryexcitingyearforKBIwiththebiggestinjectionoffreshblood!Withthebreakthroughperformanceandrapidgrowthofourresearchservices,wehaverecentlyrecruited39newstaffmembers.Ournewfamilymembersrangefromuniversitygraduates

  • 31
    2021-05

    KBI Appoints Jiming Ye (MD, PhD) as Chief Scientific Officer

    KunmingBiomedInternational(KBI)todayannouncedtheappointmentofJimingYe(MD,PhD)asChiefScientificOfficer.Dr.Yewilljoincompanyexecutiveteamtoleadthecompany’sinternalandexternaldrugdiscoveryprogramsincollaborationwithpharma

  • 23
    2018-10

    KBI’s Latest Achievements in the Development of Imaging and Circulating Biomarkers for the Assessment of Hepatic Lesions in NHP Models of NASH Will Be Presented at AASLD Liver Meeting®2018

    KunmingBiomedInternational(KBI)haspreviouslydevelopedlargecohortsofNASHandliverfibrosismodelsinnonhumanprimates(NHPs)mirroringhumanpatient’sdiseasepathophysiology,clinicalprogression,andhistopathologicalstages,includin

  • 16
    2018-10

    KBI Announces NHP Diabetic Kidney Disease Model Presentation at the American Society of Nephrology Kidney Week 2018 Annual Meeting

    KunmingBiomedInternational(KBI)hasdevelopedandcharacterizedalargecohortofdiabeticchronickidneydisease(CKD)monkeysusingquantitativeclinicallaboratoryindicatorsthatwerevalidatedagainstthehistopathologicalseveritygradingfo

  • 18
    2018-05

    KBI Announces the Appointment of Head of Eye Diseases

    KunmingBiomedInternational(KBI)announcesthehiringofKaimingZhangasHeadofEyeDiseases."WewelcomeKaimingjoiningustostrengthenKBI’scapabilityinmetaboliccomplicationssuchasdiabeticretinopathyandestablisheyediseasetechnologyp

  • 01
    2018-02

    KBI Announces the Appointment of Chief Scientific Officer

    KunmingBiomedInternational(KBI)announcesthehiringofZhimingDing,MD,Ph.D,asChiefScientificOfficer."WewelcomeZhimingjoiningourexecutivemanagementteamtofurtherstrengthencompanyscorecompetenceintranslationalnon-humanprimate(

  • 23
    2017-10

    KBI Announces the Appointment of Chief Veterinarian

    KunmingBiomedInternational(KBI)announcesthehiringofNoelMiranda,DVM,asChiefVeterinarian."TheappointmentofDr.MirandademonstratesKBIscommitmenttostrivingtheutmostcareandhighestanimalwelfarestandard.ByrecruitmentoftheChiefV

  • 15
    2017-08

    KBI’s Novel and Translational NASH/fibrosis NHP Model Development and Characterization Will Be Presented at The Liver Meeting®2017

    KunmingBiomedInternational(KBI)hasdevelopedandcharacterizedalargescaleofhighfatdiet(HFD)-inducedNHPmodelsofmetabolicdiseasesandliverdiseasesincludingsteatosis,NASHandfibrosis.Morethan1500malecynomolgusmonkeyshavebeenfed

  • 31
    2017-03

    KBI Continued Full Accreditation of AAALAC in March 2017

    OnMarch24th,2017,KunmingBiomedInternational(KBI)receivedaletterfromAAALAC(AssociationforAssessmentandAccreditationofLaboratoryAnimalCareInternational)thatKBI’sanimalcareanduseprogramisgrantedcontinuouslyfullaccreditati

  • 15
    2017-03

    KBI Exhibit at the 56th SOT Annual Meeting

    The56thSOTAnnualMeetingwhichwasorganizedbytheSocietyofToxicologytookplaceattheBaltimoreConventionCenterinBaltimore,USAMarch12to16,2017.TheSOTAnnualMeetingisthelargestmeetingofitskindandmorethan6,700attendeesfromallovert

  • 14
    2017-01

    High and New Technology Enterprise Certificate on 2016 Yunnan Province

    KunmingBiomedInternationalwasawardedtheHighandNewTechnologyEnterpriseCertificateon2016YunnanProvinceHighandNewTechnologyEnterprisesCultivatingNotificationandAwardingCeremony.YunnanProvincialScienceandTechnologyDepartmen